In the current study, we observed distinct distributions of HLA class II genotypes among subjects positive for GAD epitope-specific autoantibodies, which might explain some of the epitope spreading related to the risk of T1D. This evidence concerns the gene GAD1 and type 1 diabetes mellitus.